Ketoconazole: An Orally Effective Antifungal Agent Mechanism of Action, Pharmacology, Clinical Efficacy and Adverse Effects (Q44611755)

4 December 2017

1 reference

reason for preferred rank

title

Ketoconazole: An Orally Effective Antifungal Agent Mechanism of Action, Pharmacology, Clinical Efficacy and Adverse Effects (English)

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

2 August 2023

Ketoconazole: an orally effective antifungal agent. Mechanism of action, pharmacology, clinical efficacy and adverse effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6091064

2 August 2023

1 reference

E. B. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6091064

2 August 2023

J. C. Henry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6091064

2 August 2023

language of work or name

English

0 references

publication date

1 July 1984

1 reference

full work available at URL

4 December 2017

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1875-9114.1984.tb03356.x

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1875-9114.1984.tb03356.x

2 August 2023

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

2 August 2023

1 reference

4 December 2017

4

1 reference

4 December 2017

199-204

1 reference

4 December 2017

4

1 reference

The mechanism of action of the new antimycotic ketoconazole

4 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Laboratory and clinical assessment of ketoconazole in deep-seated mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Treatment of coccidioidomycosis with ketoconazole: An evaluation utilizing a new scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Ketoconazole in griseofulvin-resistant dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Gynecomastia with ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Ketoconazole Blocks Adrenal Steroid Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Antifungal Agents Used in Systemic Mycoses Activity and Therapeutic Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03356.X

New topical agents for dermatophytosis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

2 August 2023

2

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Mechanisms of action of the antimycotic imidazoles

2 August 2023

3

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Review of Cimetidine Drug Interactions

2 August 2023

6

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

The antifungal activity of ketoconazole

2 August 2023

8

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Activity of imidazoles against Leishmania tropica in human macrophage cultures

2 August 2023

9

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Post-therapy status of paracoccidioidomycosis treated with ketoconazole

2 August 2023

11

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Treatment of paracoccidioidomycosis with ketoconazole: A three-year experience

2 August 2023

12

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole: A New Drug for the Treatment of Paracoccidioidomycosis

2 August 2023

13

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Treatment of Paracoccidioidomycosis, Candidiasis, Chromomycosis, Lobomycosis, and Mycetoma with Ketoconazole

2 August 2023

14

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole

2 August 2023

17

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

2 August 2023

20

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole for Treatment of Disseminated Coccidioidomycosis

2 August 2023

22

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole for treatment of chronic pulmonary coccidioidomycosis

2 August 2023

23

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Chromoblastomycosis treatment with ketoconazole

2 August 2023

25

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole and Blastomycotic Osteomyelitis

2 August 2023

26

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies

2 August 2023

27

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Oral Ketoconazole in the Treatment of Leishmaniasis

2 August 2023

28

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole Treatment of Chronic Mucocutaneous Candidiasis

2 August 2023

29

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Chronic Mucocutaneous Candidosis and Other Superficial and Systemic Mycoses Successfully Treated with Ketoconazole

2 August 2023

30

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Treatment of Chronic Mucocutaneous Candidosis with Ketoconazole: A Study of 12 Cases

2 August 2023

31

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Therapy of chronic mucocutaneous candidiasis

2 August 2023

32

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood

2 August 2023

34

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Clinical Presentation of Candidal Balanitis -Its Differential Diagnosis and Treatment

2 August 2023

35

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

The treatment of patients with chronic mucocutaneous candidosis and Candida onychomycosis with ketoconazole

2 August 2023

36

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Ketoconazole therapy for fungal urinary tract infections

2 August 2023

37

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Tinea versicolor: treatment and prophylaxis with ketoconazole

2 August 2023

39

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

The successful treatment of pityriasis versicolor by systemic ketoconazole

2 August 2023

40

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Oral Therapy with Ketoconazole for Dermatophyte Infections Unresponsive to Griseofulvin

2 August 2023

42

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes

2 August 2023

43

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Oral ketoconazole for dermatophyte infections.

2 August 2023

45

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

The Activity of Ketoconazole in the Treatment of Onychomycosis

2 August 2023

48

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

2 August 2023

Ketoconazole effects

51

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial

2 August 2023

54

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Toxic hepatis during ketoconazole treatment.

2 August 2023

55

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Hepatic Dysfunction and Ketoconazole Therapy

2 August 2023

57

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

Hepatic reactions during ketoconazole treatment

2 August 2023

58

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

2 August 2023

Antifungals today

62

1 reference

https://api.crossref.org/works/10.1002/J.1875-9114.1984.TB03356.X

2 August 2023

Identifiers

1 reference

4 December 2017

1 reference